Provider Resources WA

10/06/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

| October 6, 2022
Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Since May 2022, the United States has seen more than 25,000 cases of monkeypox virus (MPV). Most cases are mild to moderate, but some people are at higher risk of severe illness: Under 8 years old. Immune compromise. Atopic dermatitis or eczema. Pregnant. Unsuppressed or uncontrolled human immunodeficiency virus (HIV). Of those currently diagnosed with MPV … 10/06/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

07/26/22 Health Advisory: Monkeypox Update

| July 27, 2022
Four doctors talking as seen from above. Two with white coats and 2 in scrubs.

We continue to monitor the monkeypox outbreak in Washington and the United States. Report possible monkeypox cases immediately upon suspicion, as Washington State Department of Health (DOH) requires. Call . We will help you complete an intake form and review exposure guidelines to evaluate close contacts. Monkeypox is rare and not often seen in the United States. It can cause a rash … 07/26/22 Health Advisory: Monkeypox Update

07/14/22 Health Advisory: Updated Monkeypox Guidance

| July 14, 2022
Exam room with vitals equipment on wall

Requested actions Washington currently has 16 reported cases of monkeypox, mostly in King County. Early cases were linked to travel but Public Health Seattle–King County announced last week the virus is likely spreading locally.  Monkeypox is rare and not often seen in the United States. It can cause a rash that looks like bumps, blisters … 07/14/22 Health Advisory: Updated Monkeypox Guidance

06/24/22 Health Advisory: Updated Monkeypox Guidance

| June 23, 2022
Scientists in lab using microscope

Requested actions Immediately report suspected monkeypox cases to Yakima County Health District. Call the reporting line at 800-535-5016 ext. 541. Consider submitting a suspect monkeypox intake form to help us determine whether to test for monkeypox. Be aware, recent confirmed cases of monkeypox in the United States differ from the classic monkeypox presentation of previous … 06/24/22 Health Advisory: Updated Monkeypox Guidance

05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

| May 12, 2022
Syringe in vial

Requested actions Background FDA limited the authorized use of J&J to people age 18 years and older: This decision came after FDA analyzed, evaluated and investigated reported cases of TTS after getting J&J. TTS is rare and includes potentially life-threatening blood clots in combination with low levels of blood platelets. Symptoms typically start 1–2 weeks … 05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

| May 5, 2022
Black triangle with an exclamation mark in the middle and "Health Advisory" written below. Appearing on yellow background.

A person in Colorado tested positive for avian influenza A(H5N1) virus (H5 bird flu), Colorado Department of Public Health and Environment reported April 28, 2022. Centers for Disease Control and Prevention (CDC) confirmed it is the first U.S. case of H5 bird flu. The person was involved in the culling of poultry with presumptive H5 … 05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine

| April 27, 2022
hands in blue medical gloves holding a syringe and drawing from a vile

Requested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use … 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

| April 27, 2022
Ariel shot of someone taking notes or completing paperwork

Requested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use … 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

04/08/22 Health Advisory: COVID-19 Information for Providers

| April 8, 2022
Female doctor with file in front of them with two other doctors at a microscope in the background.

Requested actions Be aware, on March 29, 2022, Food and Drug Administration (FDA) amended its emergency use authorization (EUA) for Moderna COVID-19 booster dose vaccine. A new multi-dose vial is now available. It has a dark blue cap and a label with a purple border. Doses from this vial are 0.5 mL. Multi-dose vials are … 04/08/22 Health Advisory: COVID-19 Information for Providers

03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups

| March 30, 2022
Syringe in vial

Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least … 03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups